Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. [electronic resource]
Producer: 20191022Description: e0210608 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzothiazoles -- pharmacology
- Biphenyl Compounds -- pharmacology
- Brain Neoplasms -- drug therapy
- Cell Death -- drug effects
- Cell Line, Tumor
- Chondroitin Sulfate Proteoglycans -- metabolism
- Drug Synergism
- Endocytosis -- drug effects
- Exotoxins -- pharmacology
- Furin -- pharmacology
- Humans
- Immunotoxins -- pharmacology
- Isoquinolines -- pharmacology
- Membrane Proteins -- metabolism
- Mice, Nude
- Models, Biological
- Nitrophenols -- pharmacology
- Piperazines -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Pyrimidines -- pharmacology
- Signal Transduction -- drug effects
- Sulfonamides -- pharmacology
- Survival Analysis
- Thiophenes -- pharmacology
- Time Factors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.